ROWENA MEYER: Open Payments
NPI 1609220037 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,400 in 40 payments from 9 companies in 2025. Trend: 2023 $1,495 · 2024 $3,146 · 2025 $5,400
Speaker / faculty: $2,730Food & beverage: $1,340Travel & lodging: $1,223Education: $107
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $4,134 |
| AstraZeneca Pharmaceuticals LP | 12 | $738 |
| Stemline Therapeutics Inc. | 9 | $161 |
| Gilead Sciences, Inc. | 3 | $156 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Caris MPI, Inc. | 1 | $50 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Corcept Therapeutics | 1 | $31 |
| Genentech USA, Inc. | 1 | $26 |
Products named: KEYTRUDA, ENHERTU, Orserdu, Trodelvy, LYNPARZA, KISQALI, MI CANCER SEEK, Korlym.
Industry payments across CA — which companies pay providers there.
